Table 3.

Resistance pattern of the different clinical isolates to ceftriaxone.

Clinical isolates	Resistance pattern
	Resistant	Intermediate	Susceptible	Total
Citrobacter species	27(52.9%)	13(25.5%)	11(21.6%)	51
E. coli	46 (73.0%)	3 (4.8%)	14 (22.2%)	61
Enterobacter species	31 (70.4)	5(11.4%)	8(18.2%)	44
K. pneumonia	12 (46.2%)	4 (15.4%)	10 (38.4%)	26
K. oxytoca	5 (83.3%)	0	1 (16.7%)	6
S. aureus	11 (4.4%)	10(4.0%)	26(10.5%)	47
Proteus species	4 (80%)	1 (20%)	0	5
Y. enterocolitica	4 (66.6%)	1 (16.7%)	1 (16.7%)	6
Total	140 (56.5)	37 (14.9%)	1 (16.7%)	248 (100)